Press Releases

Lexicon Pharmaceuticals Receives Formal Dispute Resolution Request Decision from FDA’s Office of New Drugs for Sotagliflozin in Type 1 Diabetes	Dec 02, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Nov 26, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Nov 14, 2019
Lexicon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides a Business Update	Nov 07, 2019
Lexicon Pharmaceuticals to Host Third Quarter 2019 Financial Results Conference Call and Webcast on November 7, 2019	Nov 01, 2019
Lexicon Pharmaceuticals Announces Poster Presentations at the NANETS Annual Multidisciplinary NET Medical Symposium	Oct 02, 2019
Lexicon Pharmaceuticals Announces Termination of Alliance and Settlement with Sanofi	Sep 10, 2019
Lexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 55th Annual Meeting	Sep 10, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Aug 30, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	Aug 09, 2019